ArdCoin (ARDX) news

Ardelyx Q3 2026 net loss narrows 24% to $737,000

BRIEF-Ardelyx Q3 Product Sales USD 125.455 Million

Ardelyx 3Q EPS 0c >ARDX

Ardelyx 3Q Rev $127.7M >ARDX

Ardelyx 3Q Loss $737,000 >ARDX

-- Earnings Flash (ARDX) Ardelyx, Inc. Reports Q3 Revenue $125.5M, vs. FactSet Est of $128.0M

Ardelyx Completes Enrollment in Phase 3 Ibsrela Trial in Chronic Idiopathic Constipation

Ardelyx Completes Enrollment Ahead of Schedule in Phase 3 IBSRELA Trial for Chronic Idiopathic Constipation

Ardelyx real-world study shows phosphate reductions after Xphozah initiation in dialysis patients

Ardelyx Sets Third-Quarter 2026 Financial Results Call